Thus, the first identification of JAK2–STAT3–MMPs axis as a new target of CEP55 might help to elucidate how CEP55 drives cancer propagation, in particular, its contribution to the design of effective therapeutic strategies for treating human HCC. The gene discussed is STAT3; the disease is hepatocellular carcinoma.